Go Pro

Merit Medical Systems (MMSI) Competitors

Merit Medical Systems logo
$74.32 +1.21 (+1.66%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$74.25 -0.07 (-0.09%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MMSI vs. ADUS, HQY, MEDP, AMN, and ELV

Should you buy Merit Medical Systems stock or one of its competitors? MarketBeat compares Merit Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Merit Medical Systems include Addus HomeCare (ADUS), HealthEquity (HQY), Medpace (MEDP), AMN Healthcare Services (AMN), and Elevance Health (ELV). These companies are all part of the "medical" sector.

How does Merit Medical Systems compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Merit Medical Systems has a net margin of 9.03% compared to Addus HomeCare's net margin of 6.89%. Merit Medical Systems' return on equity of 13.54% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.89% 9.80% 7.34%
Merit Medical Systems 9.03%13.54%7.94%

Addus HomeCare has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Merit Medical Systems had 8 more articles in the media than Addus HomeCare. MarketBeat recorded 12 mentions for Merit Medical Systems and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.00 beat Merit Medical Systems' score of 0.85 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.50$95.91M$5.4121.17
Merit Medical Systems$1.52B2.92$128.49M$2.3132.17

Addus HomeCare currently has a consensus target price of $131.50, indicating a potential upside of 14.80%. Merit Medical Systems has a consensus target price of $92.80, indicating a potential upside of 24.87%. Given Merit Medical Systems' higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Merit Medical Systems beats Addus HomeCare on 11 of the 17 factors compared between the two stocks.

How does Merit Medical Systems compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

HealthEquity has higher earnings, but lower revenue than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.34B5.92$215.20M$2.6735.45
Merit Medical Systems$1.52B2.92$128.49M$2.3132.17

HealthEquity has a net margin of 17.25% compared to Merit Medical Systems' net margin of 9.03%. HealthEquity's return on equity of 14.75% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.25% 14.75% 9.22%
Merit Medical Systems 9.03%13.54%7.94%

HealthEquity has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

HealthEquity presently has a consensus price target of $110.93, indicating a potential upside of 17.21%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 24.87%. Given Merit Medical Systems' higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

In the previous week, HealthEquity had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 13 mentions for HealthEquity and 12 mentions for Merit Medical Systems. HealthEquity's average media sentiment score of 1.38 beat Merit Medical Systems' score of 0.85 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

HealthEquity beats Merit Medical Systems on 12 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to Medpace?

Merit Medical Systems (NASDAQ:MMSI) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

Merit Medical Systems currently has a consensus target price of $92.80, indicating a potential upside of 24.87%. Medpace has a consensus target price of $560.92, indicating a potential downside of 6.73%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts clearly believe Merit Medical Systems is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Medpace
1 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.07

Medpace has a net margin of 17.67% compared to Merit Medical Systems' net margin of 9.03%. Medpace's return on equity of 110.15% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
Medpace 17.67%110.15%24.84%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 20.5% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Medpace has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B2.92$128.49M$2.3132.17
Medpace$2.53B6.79$451.12M$17.0635.25

In the previous week, Medpace had 23 more articles in the media than Merit Medical Systems. MarketBeat recorded 35 mentions for Medpace and 12 mentions for Merit Medical Systems. Medpace's average media sentiment score of 1.03 beat Merit Medical Systems' score of 0.85 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
17 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

Summary

Medpace beats Merit Medical Systems on 12 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to AMN Healthcare Services?

Merit Medical Systems (NASDAQ:MMSI) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

In the previous week, Merit Medical Systems had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 12 mentions for Merit Medical Systems and 4 mentions for AMN Healthcare Services. Merit Medical Systems' average media sentiment score of 0.85 beat AMN Healthcare Services' score of 0.04 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Merit Medical Systems has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B2.92$128.49M$2.3132.17
AMN Healthcare Services$2.73B0.47-$95.70M-$0.87N/A

Merit Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market.

Merit Medical Systems presently has a consensus target price of $92.80, suggesting a potential upside of 24.87%. AMN Healthcare Services has a consensus target price of $29.00, suggesting a potential downside of 11.80%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Merit Medical Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

Merit Medical Systems has a net margin of 9.03% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
AMN Healthcare Services -0.95%18.01%5.19%

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Merit Medical Systems beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to Elevance Health?

Merit Medical Systems (NASDAQ:MMSI) and Elevance Health (NYSE:ELV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

Merit Medical Systems has a net margin of 9.03% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
Elevance Health 2.47%14.64%5.22%

Merit Medical Systems currently has a consensus target price of $92.80, indicating a potential upside of 24.87%. Elevance Health has a consensus target price of $440.90, indicating a potential upside of 16.83%. Given Merit Medical Systems' higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Elevance Health had 18 more articles in the media than Merit Medical Systems. MarketBeat recorded 30 mentions for Elevance Health and 12 mentions for Merit Medical Systems. Elevance Health's average media sentiment score of 1.19 beat Merit Medical Systems' score of 0.85 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
4 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has higher revenue and earnings than Merit Medical Systems. Elevance Health is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B2.92$128.49M$2.3132.17
Elevance Health$199.13B0.41$5.66B$22.5016.77

Merit Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

Summary

Elevance Health beats Merit Medical Systems on 9 of the 16 factors compared between the two stocks.

Get Merit Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MMSI vs. The Competition

MetricMerit Medical SystemsMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$4.36B$16.50B$6.88B$12.26B
Dividend YieldN/A1.33%2.67%9.79%
P/E Ratio32.1718.8727.0023.71
Price / Sales2.922.13492.7776.09
Price / Cash12.4413.9650.5459.64
Price / Book2.783.2110.286.07
Net Income$128.49M$534.24M$3.60B$331.84M
7 Day Performance0.45%-2.71%-1.25%-1.53%
1 Month Performance4.93%0.42%-0.35%-2.46%
1 Year Performance-12.24%-3.81%18.41%13.66%

Merit Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MMSI
Merit Medical Systems
3.8715 of 5 stars
$74.32
+1.7%
$92.80
+24.9%
-11.8%$4.36B$1.52B32.177,500
ADUS
Addus HomeCare
3.2392 of 5 stars
$108.86
+0.6%
$131.50
+20.8%
+5.9%$2.02B$1.42B20.1250,659
HQY
HealthEquity
4.2176 of 5 stars
$95.66
+1.3%
$110.57
+15.6%
+0.3%$7.89B$1.31B35.832,814
MEDP
Medpace
2.0137 of 5 stars
$530.19
-1.5%
$469.50
-11.4%
+32.0%$15.37B$2.53B33.326,200
AMN
AMN Healthcare Services
1.7072 of 5 stars
$33.97
+4.9%
$27.00
-20.5%
+67.7%$1.26B$2.73BN/A2,664

Related Companies and Tools


This page (NASDAQ:MMSI) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners